Medline Is Said to Raise About $6.26 Billion in Upsized IPO
Summarize this article with:
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the worldAmericas+1 212 318 2000EMEA+44 20 7330 7500Asia Pacific+65 6212 1000Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the worldAmericas+1 212 318 2000EMEA+44 20 7330 7500Asia Pacific+65 6212 1000A Medline Inc. facility in Wilmer, Texas.Photographer: Tripplaar Kristoffer/SIPA/AP PhotoMedline Inc. raised about $6.26 billion in an upsized initial public offering, pricing its shares near the top of a marketed range, according to a person familiar with the matter.The company sold 216 million shares Tuesday for $29 each, said the person, who asked not to be identified because the information wasn’t public yet. Medline, which counts Blackstone Inc., Carlyle Group Inc. and Hellman & Friedman among its backers, had marketed 179 million shares for $26 to $30 each, according to its filings with the US Securities and Exchange Commission.